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Summary 31P magnetic resonance spectroscopy (MRS) in vivo and in vitro was used to study modulation of
host liver (HL) metabolism in rats bearing the MAT-LyLu variant of the Dunning prostate tumour. Animals
were inoculated either with 106 or 107 MAT-LyLu cells, or with saline to serve as controls. Carcass weight in
tumour-bearing (TB) animals decreased despite similar food and water intake in both groups. Absence of
metastatic tumour cells from HL of all TB animals was confirmed by histological examination. Twenty-one
days after inoculation, "P MRS showed a 2.5-fold increase in [Pi]/[ATP] ratios in HL in vivo (P<0.001)
which was confirmed by "P MRS of liver extracts in vitro (P<0.005). Phosphodiester to ATP ratios were
significantly increased (P <0.05) in HL in vivo, but absolute PDE levels were similar in both groups.
Phosphomonoester to ATP ratios did not change, although absolute phosphomonoester levels in HL were
reduced by -41% (not significant). In HL extracts in vitro, sharp reductions in the levels of glucose-6-
phosphate (P <0.05), fructose-6-phosphate (P=0.05), phosphocholine (P<0.001), glycerophosphocholine
(P<0.001), and glycerophosphoethanolamine (P<0.001) were observed. Electron microscopy revealed in-
creased amounts and altered distribution of rough endoplasmic reticulum in HL. These findings show that
experimental prostate cancer significantly affects hepatic phosphorylation status, phospholipid metabolism,
and gluconeogenesis in the host animal, and demonstrate the value of combined MRS in vivo and in vitro in
monitoring HL metabolism in cancer.
In the USA and the United Kingdom, prostate cancer is the
third leading cause of male death from malignant disease. A
generalised increase in the incidence of prostatic cancer has
occurred throughout the world during the past 25 years so
that it is now greater than 30% in men over 50 years of age
and rises to 80% by age 80 years. At the time of diagnosis,
approximately 75% of patients already have either locally
extensive or metastatic disease. Presently, no reliable tumour-
markers are available with which to assess, independently,
functional differentiation within human prostatic cancers or
to determine the effect a particular malignancy will exert on
an individual patient (Foster, 1991).
It has been known for many years that the cancer-bearing
state is generally associated with profound alterations in host
metabolism, contributing significantly to the syndrome of
cancer cachexia and ultimately death (Lawson et al., 1982;
Kern & Norton, 1988; Rossi-Fanelli et al., 1991). Many of
these aberrations, including increased Cori cycle activity, in-
creased protein turnover and hyperlipidemia, relate to
changes in the host liver (i.e. liver without metastatic
disease). Thus, in the host liver of tumour-bearing (TB)
animals, a reduced phosphorylation state (Argiles & Lopez-
Soriano, 1991) as well as increases in energy expenditure
(Roh et al., 1985), gluconeogenesis (Noguchi et al., 1989; Liu
et al., 1990), and protein synthesis (Ternell et al., 1988) were
reported. Increased hepatic phospholipid concentrations
relative to triglyceride concentrations were also observed
(Nakazawa & Mead, 1976). These alterations are associated
with marked changes in liver enzyme activities and prominent
reexpression of fetal isoenzymes (Herzfeld & Greengard,
1972, 1977).
One approach to investigating the relationship between
metastatic phenotype and host status is by means of a
reliable tumour-model. The Dunning R-3327 rat prostate
cancer model resembles the human disease in its appearance,
metastatic behaviour and ability to produce multiple sublines
of varied phenotype. The original tumour was derived from a
Copenhagen rat prostatic dorsal lobe carcinoma (Dunning,
1963) and proved to be serially transplantable into the flanks
of both Copenhagen and Copenhagen/Fisher Fl hybrid rats
(Lubaroff et al., 1980). Of the several well characterised
behavioural phenotypes that have been cloned from this
tumour, the MAT-LyLu subline rapidly metastasizes to
lymph nodes and lungs, but not to the liver (Isaacs & Coffey,
1983).
In the present study, we used the MAT-LyLu subline in
order to investigate the effect of prostatic cancer on the
metabolism of the liver as a major host organ, using 31P
magnetic resonance spectroscopy (MRS) in vivo and in vitro.
31P MRS is a non-invasive technique which has been previ-
ously used in the study of hepatic physiology and disease
(Meyerhoff et al., 1990; Oberhaensli et al., 1990; Cox et al.,
1992a). 31P MRS can detect a wide range of metabolites,
including intermediates of phospholipid metabolism and
glycolysis/gluconeogenesis, adenine nucleotides, and Pi
(Radda et al., 1989).
Materials and methods
Animalpreparation
MAT-LyLu rat prostate carcinoma cells were obtained from
Dr J. Isaacs (Johns Hopkins Cancer Center, Baltimore, USA)
and cultured as previously described (Bashir et al., 1990). At
confluence, cells were harvested using 0.025% trypsin in
10 mM sodium phosphate buffer (pH7.4) without Ca2" or
Mg2 . In two subsequent experiments, adult male
Copenhagen-Fisher Fl hybrid rats (Harlan-Olac Ltd,
Bicester, Oxford, UK) were inoculated into subcutaneous
tissues of the left flank with either I x 107 (experiment 1,
n = 3) or 1 x 106 (experiment 2, n = 6) tumour cells
suspended in 500 of sterile saline. Apart from the number
of inoculated cells, the design of the two experiments was
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identical. Control animals were inoculated with saline
(experiment 1: n = 4, experiment 2: n = 5). Thereafter,
animals were maintained in adjacent individual cages with
water and standard rat chow (Pilsbury's Ltd, Birmingham,
UK) available ad libitum. Body weight, and food and water
intake were monitored daily. Carcass weight was calculated
by subtracting weight of primary and metastatic tumours
from total body weight. At 21 days after inoculation, animals
were fasted overnight and anaesthetised using 0.5 ml kg-'
HypnormR (Janssen Pharmaceutical Ltd, Grove, Oxford,
UK; containing 0.315 mg fentanyl citrate and 10 mg
fluanisone per ml), and 1 mg kg-' Hypnovel (Midezolam;
Roche Laboratories, Division of Hoffmann-La Roche Inc,
Nutley, N.J. 07110). A midline laparotomy was performed
and a two turn, 14 mm diameter coil was placed directly onto
the liver. Animals were maintained at 37°C throughout the
experiment via a heated pad.
MRS in vivo
MRS data were acquired in vivo using a SIS-200 MR imaging
spectrometer interfaced to an Oxford Instruments 4.7 Tesla,
30 cm bore superconducting magnet. In order to optimise the
magnetic field homogeneity in the region of the coil, the coil
was transmission line tuned to 200.06 MHz for detection of
'H MRS signals. Typical linewidths of 50 Hz were observed
for the water resonance. 3'P MRS data were acquired with
the coil tuned to 80.98 MHz, using a pulse of approximately
450 at the center of the coil, and repetition time (TR) of both
1.5 and 8 s (256 and 64 signal averages, respectively). Spec-
tral quantitation of 3'P MRS data was carried out in a
similar manner as described previously by Cox et al (1992a),
after baseline correction for the broad phospholipid signal as
described in Bates et al. (1989). Data were weighted by line
broadening of 20 Hertz prior to Fourier transformation.
MRS in vitro
On completion of MRS in vivo, part of the liver was freeze-
clamped at liquid nitrogen temperature (Bates et al., 1988).
In experiment 1, the liver was removed prior to freeze-
clamping, whereas in experiment 2, liver tissue was freeze-
clamped in situ in order to prevent ischaemia. Therefore, for
the measurement of concentrations of adenine nucleotides,
inorganic phosphate, and sugar phosphates, only data from
experiment 2 were included in this paper. Tissue samples
were extracted with perchloric acid (Bates et al., 1988), and
adjusted to pH = 7.5 using potassium hydroxide. The result-
ing supernatant was lyophilised and redissolved in D20.
After adding EDTA to a final concentration of ca. 100 mM,
pH was readjusted to 7.5. High-resolution 3'P MRS spectra
were acquired on a 8.4 Tesla Bruker system, using a 35°
excitation pulse with TR 10 s. Proton scalar coupling interac-
tions were removed by using low power proton decoupling.
Phosphocreatine was added as an internal chemical shift
reference and concentration standard.
Microscopy
For light microscopy, specimens were fixed in fresh neutral-
buffered formalin (10% v/v). After routine embedding in
paraffin wax, tissue sections were cut at 3gm and stained
with hematoxylin and eosin. For electron microscopy, 1 mm-
cubes of tissue were fixed in 2% glutaraldehyde in sodium
phosphate-buffer (pH7.2, 0.2 M). Tissue blocks were post
fixed in 1% osmium tetroxide in Millonig's buffer (Millonig,
1961) 1 h at room temperature. Thereafter, following two
washes for 30 min each in distilled water, blocks were dehy-
drated in graded alcohols followed by three changes of
TAABR resin (TAAB Laboratories, Aldermaston RG7 4QW,
UK) for 1 h each. Tissue blocks were embedded in poly-
ethylene capsules (BEEM capsules, TAAB Laboratories, ad-
dress as above) in fresh identical resin. Polymerisation was
performed at 60°C overnight. Blocks were cut at 1 ym on a
Reichert ultramicrotome using a glass knife. Ultrathin sec-
tions of selected areas were then cut at 80 nm using a
diamond knife. Sections were taken onto uncoated nickel
grids and stained in saturated methanolic urinyl acetate for
3 min followed by Reynold's lead citrate (Reynolds, 1963) for
8 min, both at room temperature. After drying, sections were
examined and photographed using a Philips CM1O electron
microscope at 80 kV.
Statistical analysis
Results are expressed as means ± s.e.m. in lsmol perg wet
weight and analysed for significance by Student's t-test for
independent groups. For data not distributed normally (i.e.
Pi/ATP ratios in vivo and in vitro), Wilcoxon's rank sum test
is used. P-values <0.05 are considered significant. For data
from experiment 2 only, absolute phosphomonester (PME)
and phosphodiester (PDE) concentrations in vivo were cal-
culated by multiplying [PME]/[APT] and [PDE]/[ATP] ratios
in vivo at TR = 8 s by ATP concentrations as measured in
vitro. The validity of this calculation is supported (1) by the
notion that all intracellular ATP in rat liver is MRS-visible in
vivo (Iles et al., 1985; Desmoulin et al., 1987), and (2) by
optimisation of our protocol in vivo which indicated that a
TR of greater than or equal to 8 s gave the same metabolite
ratios.
Results
Animals
In all host animals, tumours grew subcutaneously at sites of
inoculation. No ulceration of overlying skin was seen in any
of the animals. At 21 days following inoculation, when the
experiments were terminated, all primary tumours were
between 3 and 5 cm in diameter. Food and water intake of
TB animals were within 10% of the control values, and no
relation between these variables and test results was
observed. Total body weight at the end of the study was
similar in both groups of animals, but carcass weight of TB
animals had decreased by 13 ± 2% (mean ± s.e.m.) during
the 21-day study period, whereas body weight of NTB
animals had increased by 7 ± 2% (difference TB vs NTB
animals: P<0.001).
Histology
Histological examination revealed no metastatic tumour cells
to be present in multiple sections of the livers from TB
animals, despite the growth ofmetastatic tumours up to 1 cm
diameter in abdominal lymph nodes and within lung paren-
chyma. No difference in cell volume or cell density of
hepatocytes was observed between TB and NTB animals.
MRS in vivo
3'P MRS spectra in vivo from the liver of TB animals (host
liver) and NTB animals (control) revealed no significant
difference in signal-to-noise (Figure 1 a,b). Spectra (Figure 1,
Table I) showed a 2.5-fold increase in [Pi]/[ATP] ratios in the
host liver as compared to control liver. Phosphodiester
(PDE) to ATP ratios in host liver were significantly increased
(+ 28%), but absolute PDE levels in host and control liver
were similar (mean ± s.e.m. :4.54 ± 1.00 vs 4.48 ± 0.56tLmol
perg wet weight). No changes in [PME]/[ATP] were observed.
Although absolute PME levels in the host liver were reduced
by 40%/O, the difference from control values did not reach
statistical significance (4.01 ± 1.00 vs 6.85 ± 1.47 ltmol perg
wet weight, P>0.05).
MRS in vitro
3'P MRS of liver extracts in vitro (Figure 2, Table II) showed
a 2.1-fold increase in [Pi]/[ATP] ratios in the host liver. ATP
concentrations were reduced by 28% in the host liver, but theHOST LIVER METABOLISM IN PROSTATE CANCER 1305
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Figure 1 31PMRS spectra in vivo a, the host liver of a tumour-bearing rat and b, the liver of a control rat. Peak assignments:
a-ATP, 1-ATP, y-ATP: o-, P-, and y-phosphate groups of ATP; PDE, phosphodiesters; PME, phosphomonoesters.
difference as compared to control liver was not significant
(P>0.05). No changes in [ADP] and [AMP] were detected.
Marked reductions in phosphocholine (- 49%), glycerophos-
Table I Metabolite concentrations in vivo in the host liver of
tumour-bearing rats (n = 9) and the liver of control rats (n = 9), as
determined by 31P MRS. Values shown are means ± s.e.m. Abbrevi-
ations: PDE, phosphodiesters; PME, phosphomonoesters
Tumour-bearing Control
[Pi]/[ATP] 1.83 ± 0.32 0.74 ± 0.06a
[PME]/[ATP] 1.47 ± 0.14 1.57 ± 0.22
[PDE]/[ATP] 1.62 ± 0.12 1.27 ± 0.09b
Tumour-bearing vs control. ap <0.001 (Wilcoxon's rank sum
test). bp <0.05 (t-test).
phocholine (GPC,- 76%) and glycerophosphoethanolamine
(GPE, - 85%) concentrations were observed in the host liver
(Figure 2, Table III), but phosphoethanolamine concentra-
tions were not altered. Glucose-6-phosphate (G6P) concen-
trations in the host liver were decreased by 63% and fruc-
tose-6-phosphate (F6P) concentrations by 73% (Table IV).
No significant changes in concentrations of 3-phospho-
glycerate, glyceraldehyde-3-phosphate or sn-glycerol-3-
phosphate were observed (P>0.05).
Within the TB group, MRS findings in vivo and in vitro
were not significantly related with tumour load or carcass
weight (P>0.05). Phosphocholine and ATP concentrations
in vitro were significantly correlated (r = 0.83, P = 0.001).
Furthermore, the sum of phosphocholine, G6P and F6P
concentrations as detected in vitro was significantly correlated
with PME levels in vivo (r = 0.79, P<0.00l).1306 P.C. DAGNELIE etal.
Table III Concentrations, determined by 31P MRS in vitro, of
intermediates of phospholipid metabolism in the host liver of
a tumour-bearing rats (n = 9) and the liver of control rats (n = 9).
Values shown are means ± s.e.m.
IPi
y-ATP
Phosphocholine
Phosphoethanolamine
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Glycerophosphoethanolamine
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Figure 2 31P MRS spectra of tissue extract in vitro of a, host
liver of tumour-bearing rats and b, liver of control rats. Spectra
shown are 31P MRS spectra from mixed samples (a: n = 7, b:
n = 5). Peak assignments: a-ATP, y-ATP: a- and y-phosphate
groups of ATP; G6P, glucose-6-phosphate; GPC, glycerophos-
phocholine; GPE, glycerophosphoethanolamine; NTP/NDP,
nucleotide triphosphates and diphosphates; PC, phosphocholine;
PCr, phosphocreatine (added as an internal chemical shift
reference and concentration standard); PE, phosphoethanola-
mine; X, extraction artefact.
Table II Concentrations, determined by 31P MRS in vitro, of
adenine nucleotides and inorganic phosphate in the host liver of
tumour-bearing rats (n = 6) and the liver of control rats (n = 5).
Values shown are means ± s.e.m.
Absolute concentration
ATP
ADP
AMP
Pi
Tumour-bearing
(Wmolg '
wet weight)
2.55±0.40
1.37± 0.24
0.47± 0.12
11.13 ± 2.40
Control
(fs molg-'
wet weight)
3.53 ± 0.29
1.54 ± 0.28
0.32 ± 0.07
8.43 ± 1.90
Relative concentration
Pi/ATP 4.93 ± 1.20 2.32 ± 0.41a
Tumour-bearing vs control: ap <0.05 (Wilcoxon's rank sum test).
Tumour-bearing
(pmolg-'
wet weight)
1.48 ± 0.20
0.53±0.09
0.14 ± 0.06
0.10 ± 0.03
Control
(pmolg-'
wet weight)
2.91 ± 0.32a
0.76 ± 0.22
0.58 ± 0.09a
O.67 ± 0.l0a
Tumour-bearing vs control: ap <0.001 (t-test).
Table IV Concentrations, determined by 31P MRS in vitro, of sugar
phosphates in the host liver of tumour-bearing rats (n = 6) and the
liver of control rats (n = 5). Values shown are means ± s.e.m.
Tumour-bearing Control
(tlmolg-] (1lmolg- ]
wet weight) wet weight)
Glucose-6-phosphate 0.12 + 0.04 0.32 ± 0.08a
Fructose-6-phosphate 0.17 ± 0.04 0.64 + 0.22a
Glyceraldehyde-3-phosphate 0.30 + 0.12 0.24 + 0.13
sn-Glycerol-3-phosphate 0.16 ± 0.02 0.15 + 0.04
3-Phosphoglycerate 0.29 ± 0.06 0.48 ± 0.14
Tumour-bearing vs control: ap<0.05 (t-test).
Electron microscopy
Ultrastructural studies of liver tissue revealed a generalised
increase in the amount of rough endoplasmic reticulum (ER)
in hepatocytes of livers from TB animals (Figure 3). The
subcellular distribution of the ER was also altered, when
compared with liver from control animals. In the former, the
ER was stacked closely around hepatocyte nuclei from which
it extended to infiltrate between and to surround mitochon-
dria. Generally, a much closer apposition of ER and mito-
chondria was seen in hepatocytes of TB animals than in
control hepatocytes. In addition, whereas mitochondrial mor-
phology was generally uniform in control hepatocytes, being
predominantly circular in cross-section, the morphology of
mitochondria in hepatocytes of TB animals was more
variable with many ovoid and elongated forms.
Discussion
This study has demonstrated modulation of hepatic energy
and phospholipid metabolism to occur in the host livers of
rats bearing the Dunning MAT-LyLu variant of prostatic
cancer but in the absence of liver metastases. These observa-
tions confirm specific alterations in subcellular membrane
composition and metabolism of the host liver to be a direct
consequence of the presence of a malignant neoplasm in the
host animal. The metabolic abnormalities observed here by
31p MRS in vivo are markedly distinct from alterations
previously reported in liver disease. Most liver diseases
studied by 31P MRS in vivo were characterised by increased
[PME]/[ATP] ratios with or without a reduction [PDE]/[ATP]
ratios (Angus et al., 1990; Meyerhoff et al., 1990; Oberhaensli
et al., 1990; Cox et al., 1992a, 1992b). In contrast, in this
study we observed an increase in [Pi]/[ATP] and [PDE]/[ATP
ratios as well as a tendency for reduced absolute PME
concentrations in the host liver of TB animals. The rise in
[PDE]/[ATP] was explained by a decrease in [ATP]; absolute
PDE levels did not change.
The lack of significance in the apparent fall in PME levels
in vivo may have been due to errors in estimating this peak.HOST LIVER METABOLISM IN PROSTATE CANCER 1307
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Figure 3 Ultrastructural appearances of hepatocytes from a, control livers and b, host livers of tumour-bearing rats. In each
electron micrograph the bar indicates 1 gm. In all the control livers, mitochondria appeared uniform, compact and round with
small amounts of adjacent endoplasmic reticulum. Hepatocytes from tumour-bearing animals contained increased numbers of
frequently irregularly-shaped mitochondria which were intimately surrounded by relatively increased amounts of endoplasmic
reticulum.
Since the PME peak in vivo is a multicomponent resonance
(Ling & Brauer, 1990), it is also possible that reduced intra-
cellular concentrations of some components of the PME
peak (such as phosphocholine, G6P and F6P) were compen-
sated by rising levels of other components (such as AMP)
contributing to this peak. Our observation that [PME]
measured in vivo was significantly correlated with the sum of
phosphocholine, G6P and F6P concentrations as measured in
vitro would suggest that decreased concentrations of these
compounds contributed to depressed [PME] in vivo.
Although the changes in [Pi]/[ATP] and [PME] resemble
alterations observed in normal rat liver after prolonged fast-
ing (Desmoulin et al., 1990), our findings were neither caused
by anorexia (as shown by similar food intake by TB and
NTB animals), nor by the overnight fast preceding MRS
(since control animals were also fasted overnight). The
resemblance with MRS spectra of fasted liver is therefore
remarkable and might suggest a physiological parallel
between fasting and the tumour-bearing state. One possible
explanation for this similarity would be the increase of
hepatic gluconeogenesis which has been observed in the host
liver of TB animals (Shearer et al., 1983; Noguchi et al.,
1989; Liu et al., 1990). Since gluconeogenesis has demands
on ATP supply, this could contribute to ATP depletion in
the fasting state as well as in the host liver. Although ATP
levels were decreased in TB animals, they were generally
above the critical concentration of 2 imol perg wet weight
below which they could have limited the rate of gluco-
neogenesis (Wilkening et al., 1975).
An increase in glucose-6-phosphatase activity has been
reported in host liver of TB animals (Gutman et al., 1969).
Although the relation between metabolic rate and steady
state concentrations is not straightforward, such an increase
in glucose-6-phosphatase activity could provide a possible
explanation for the fall in G6P levels observed in our
study.
Concentrations of phosphocholine, GPC and GPE were
drastically reduced in the host liver, suggesting alterations in
phospholipid metabolism related with the tumour-bearing
state. These changes in the host liver do not mimic the
alterations observed in tumourous tissue, where increases in
phosphocholine, and sometimes also phosphoethanolamine,
GPC and GPE levels, are observed (Daly & Cohen, 1989;
Podo et al., 1987). In rat mammary tumours, phosphocholine
levels were positively but GPC and GPE levels negatively
related with indices of cell growth (Smith et al., 1991).
Phosphocholine, which is synthesised from choline within
ATP the choline kinase reaction, is a precursor for phos-
phatidylcholine synthesis. There is some evidence supporting
a role of the choline kinase reaction in the regulation of
phosphatidylcholine synthesis (review in Tijburg et al., 1989).
The reported Km of choline kinase for ATP in rat liver is
3.7 mM (Pelech & Vance, 1984), so that the low ATP levels
observed in host liver (range 1.27- 4.03 mM) could have been
rate-limiting for this reaction. This hypothesis is supported
by the high correlation observed between phosphocholine
and ATP concentrations in host liver.
The cause of the decrease in GPC and GPE concentrations
is uncertain. GPC and GPE are produced by hydrolysis of
phosphatidylcholine and phosphatidylethanolamine, respec-
tively, but little is known about their metabolic function.
Elevated GPC and GPE levels in mouse tumours were re-
duced after antitumour treatment, and the concomitant rise
in glycerol-3-phosphate levels suggested increased GPC and
GPE breakdown (Podo et al., 1987). However, in spite of
marked reductions in GPC and GPE levels in the host liver,
we did not observe an increase in glycerol-3-phosphate con-
centrations in this organ.
The PDE resonance in vivo contains contributions from
GPC and GPE as well as from phospholipid headgroups of
subcellular membranes (Bates et al., 1989), especially the ER
(Murphy et al., 1989). Assuming that the water-soluble com-
pounds GPC and GPE are MRS-visible in vivo, in our study
they may account for a maximum of 5% of the PDE signal
in vivo in host liver, and 28% in control liver. Since total
PDE levels in host and control liver were not different, this
implies that the contribution of the ER to the PDE signal
was probably increased in the host liver. The increased size
of ER in the host liver detected by ultrastructural studies
would provide an explanation for this higher intensity of the
iB
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MRS signal derived from the ER. The increased ER is also
compatible with the elevated hepatic phospholipid content
which was reported in the host liver of human patients with
various tumours (Nakazawa & Yamagata, 1971) and later
confirmed in a mouse model (Nakazawa & Mead, 1976). The
increased proximity ofrough ER to hepatocyte mitochondria
identified by electron microscopy in TB animals (Figure 3)
supports the notion of an enhanced level of physical and
functional contact between these two organelles.
In conclusion, we have used a well-characterised rat model
ofprostate cancer to investigate the effects ofthis malignancy
on the host liver - an organ not directly involved by the
neoplasm. The study has shown clear structural and meta-
bolic alterations to occur in a reproducible and predictable
manner within the liver. This study not only supports earlier
reports of an increased [Pi]/[ATP] ratio in the host liver of
rats with transplanted sarcomas (Schneeberger et al., 1989)
but it emphasises MRS as a valuable and non-invasive
modality with which to monitor and to improve the manage-
ment of patients with prostatic and other malignancies.
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